US Stock MarketDetailed Quotes

MBX MBX Biosciences

Watchlist
  • 7.760
  • +0.350+4.72%
Close Mar 28 16:00 ET
  • 7.760
  • 0.0000.00%
Post 16:05 ET
259.37MMarket Cap-4.19P/E (TTM)

MBX Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(FY)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
93.12%68.19M
86.27%18.61M
79.19%19.61M
40.34%35.31M
9.99M
10.95M
25.16M
Selling and administrative expenses
59.05%10.78M
49.60%3.39M
53.04%2.87M
80.05%6.78M
--2.26M
--1.87M
--3.76M
-General and administrative expense
59.05%10.78M
49.60%3.39M
53.04%2.87M
80.05%6.78M
--2.26M
--1.87M
--3.76M
Research and development costs
101.22%57.42M
97.01%15.22M
84.58%16.75M
33.36%28.53M
--7.73M
--9.07M
--21.4M
Operating profit
-93.12%-68.19M
-86.27%-18.61M
-79.19%-19.61M
-40.34%-35.31M
-9.99M
-10.95M
-25.16M
Net non-operating interest income expense
128.24%6.27M
163.41%3.02M
87.74%1.47M
137,500.00%2.75M
1.15M
783K
-2K
Non-operating interest income
128.24%6.27M
163.41%3.02M
87.74%1.47M
638.71%2.75M
--1.15M
--783K
--372K
Non-operating interest expense
----
----
----
----
----
----
--374K
Other net income (expense)
-972K
Gain on sale of security
----
----
----
----
----
----
---73K
Special income (charges)
----
----
----
----
----
----
---899K
-Less:Other special charges
----
----
----
----
----
----
--899K
Income before tax
-90.16%-61.92M
-76.25%-15.59M
-78.53%-18.14M
-24.60%-32.56M
-8.84M
-10.16M
-26.14M
Income tax
Net income
-90.16%-61.92M
-76.25%-15.59M
-78.53%-18.14M
-24.60%-32.56M
-8.84M
-10.16M
-26.14M
Net income continuous Operations
-90.16%-61.92M
-76.25%-15.59M
-78.53%-18.14M
-24.60%-32.56M
---8.84M
---10.16M
---26.14M
Minority interest income
Net income attributable to the parent company
-90.16%-61.92M
-76.25%-15.59M
-78.53%-18.14M
-24.60%-32.56M
-8.84M
-10.16M
-26.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-90.16%-61.92M
-76.25%-15.59M
-78.53%-18.14M
-24.60%-32.56M
-8.84M
-10.16M
-26.14M
Basic earnings per share
-469.32%-5.82
-69.30%-0.47
-771.42%-2.78
-24.60%-1.0223
-0.2776
-0.319
-0.8205
Diluted earnings per share
-469.32%-5.82
-69.30%-0.47
-771.42%-2.78
-24.60%-1.0223
-0.2776
-0.319
-0.8205
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(FY)Dec 31, 2022
Total revenue 0000000
Operating revenue --0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 93.12%68.19M86.27%18.61M79.19%19.61M40.34%35.31M9.99M10.95M25.16M
Selling and administrative expenses 59.05%10.78M49.60%3.39M53.04%2.87M80.05%6.78M--2.26M--1.87M--3.76M
-General and administrative expense 59.05%10.78M49.60%3.39M53.04%2.87M80.05%6.78M--2.26M--1.87M--3.76M
Research and development costs 101.22%57.42M97.01%15.22M84.58%16.75M33.36%28.53M--7.73M--9.07M--21.4M
Operating profit -93.12%-68.19M-86.27%-18.61M-79.19%-19.61M-40.34%-35.31M-9.99M-10.95M-25.16M
Net non-operating interest income expense 128.24%6.27M163.41%3.02M87.74%1.47M137,500.00%2.75M1.15M783K-2K
Non-operating interest income 128.24%6.27M163.41%3.02M87.74%1.47M638.71%2.75M--1.15M--783K--372K
Non-operating interest expense --------------------------374K
Other net income (expense) -972K
Gain on sale of security ---------------------------73K
Special income (charges) ---------------------------899K
-Less:Other special charges --------------------------899K
Income before tax -90.16%-61.92M-76.25%-15.59M-78.53%-18.14M-24.60%-32.56M-8.84M-10.16M-26.14M
Income tax
Net income -90.16%-61.92M-76.25%-15.59M-78.53%-18.14M-24.60%-32.56M-8.84M-10.16M-26.14M
Net income continuous Operations -90.16%-61.92M-76.25%-15.59M-78.53%-18.14M-24.60%-32.56M---8.84M---10.16M---26.14M
Minority interest income
Net income attributable to the parent company -90.16%-61.92M-76.25%-15.59M-78.53%-18.14M-24.60%-32.56M-8.84M-10.16M-26.14M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -90.16%-61.92M-76.25%-15.59M-78.53%-18.14M-24.60%-32.56M-8.84M-10.16M-26.14M
Basic earnings per share -469.32%-5.82-69.30%-0.47-771.42%-2.78-24.60%-1.0223-0.2776-0.319-0.8205
Diluted earnings per share -469.32%-5.82-69.30%-0.47-771.42%-2.78-24.60%-1.0223-0.2776-0.319-0.8205
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------
Market Insights
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.